Capitolis Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-55,000
| Closed | -$27.9M | – | 56 |
|
|
2022
Q3 | $27.9M | Buy |
55,000
+14,504
| +36% | +$7.36M | 1.98% | 18 |
|
|
2022
Q2 | $22M | Buy |
40,496
+40,000
| +8,065% | +$21.7M | 1.15% | 27 |
|
|
2022
Q1 | $293K | Sell |
496
-142,131
| -100% | -$84M | 0.01% | 115 |
|
|
2021
Q4 | $95.2M | Buy |
142,627
+76,970
| +117% | +$51.4M | 0.57% | 41 |
|
|
2021
Q3 | $38.6M | Buy |
65,657
+25,180
| +62% | +$14.8M | 0.35% | 63 |
|
|
2021
Q2 | $20.4M | Buy |
40,477
+13,869
| +52% | +$7M | 0.24% | 98 |
|
|
2021
Q1 | $12.1M | Hold |
26,608
| – | – | 0.21% | 106 |
|
|
2020
Q4 | $12.4M | Buy |
+26,608
| New | +$12.4M | 0.21% | 118 |
|